Financials data is unavailable for this security.
View more
Year on year BioArctic AB grew revenues 169.83% from 228.29m to 616.00m while net income improved from a loss of 11.18m to a gain of 229.25m.
Gross margin | 88.22% |
---|---|
Net profit margin | -29.49% |
Operating margin | -32.08% |
Return on assets | -7.96% |
---|---|
Return on equity | -9.18% |
Return on investment | -8.90% |
More ▼
Cash flow in SEKView more
In 2023, cash reserves at BioArctic AB fell by 193.82m. However, the company earned 309.69m from its operations for a Cash Flow Margin of 50.28%. In addition the company generated 14.06m cash from financing while 507.49m was spent on investing.
Cash flow per share | 0.5336 |
---|---|
Price/Cash flow per share | 222.36 |
Book value per share | 10.52 |
---|---|
Tangible book value per share | 10.52 |
More ▼
Balance sheet in SEKView more
Current ratio | 7.18 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0642 |
---|---|
Total debt/total capital | 0.0604 |
More ▼
Growth rates in SEK
SmartText is unavailable
EPS growth(5 years) | -9.76 |
---|---|
EPS (TTM) vs TTM 1 year ago | -133.65 |